Expanded cohort reiterates strong adherence rate of over 90% for Shield blood-based colorectal cancer screening test Survey findings show eligible individuals prefer a blood test for colorectal cancer ...

Proteomics International has launched PromarkerEso at the ISDE World Congress in Brisbane (18–20 September). PromarkerEso is a world-first protein biomarker-based blood diagnostic that can rule out ...

A team of scientists from the United Kingdom has developed a new blood test that could change the way lung cancer is detected and monitored. A new study talks about using the Fourier Transform ...

Dec. 2 (UPI) --As new blood tests capable of detecting dozens of cancers in their early stages are hitting the market, disease prevention advocates say political and economic momentum is building for ...

UC San Diego Health is the first health system in the country to offer a new blood test for testicular cancer, officials announced Monday. The test, a decade in the making, is being touted by UCSD ...

A Bay Area biotech company says its groundbreaking blood test can detect more than 50 cancers. Early detection can improve cancer outcomes and can save lives. Cancer is the second leading cause of ...

Kentucky has one of the highest rates of colorectal cancer in the US, but early detection leads to a 91% five-year survival rate. Colorectal cancer is projected to become the leading cancer killer for ...

Roche has claimed the exclusive international rights to Freenome’s multiomic cancer screening approaches, toward the goal of developing blood testing kits for markets outside the U.S. The licensing ...

UC San Diego Health is the first health system in the country to offer a new blood test for testicular cancer, officials announced Monday. The test, a decade in the making, is being touted by UCSD ...

Colon cancer is the second-deadliest cancer in the US, partly due to low screening rates. New and emerging screening tools, like blood and breath tests, may offer alternatives to in-office screenings.